{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:39Z","timestamp":1791247959060,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00944-5","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:49:02Z","timestamp":1791200942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis"],"prefix":"10.1007","volume":"204","author":[{"given":"Hee-Young","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Suk","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjin","family":"Jegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongseok","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Guen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5121-3522","authenticated-orcid":false,"given":"Jin Woo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"944_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-031-12950-6_19","volume-title":"Orphan lung diseases: a clinical guide to rare lung disease","author":"SR Johnson","year":"2023","unstructured":"Johnson SR (2023) Lymphangioleiomyomatosis. In: Cottin V, Richeldi L, Brown K et al (eds) Orphan lung diseases: a clinical guide to rare lung disease. Springer International Publishing, Cham, pp 335\u2013351"},{"issue":"11","key":"944_CR2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","volume":"9","author":"C McCarthy","year":"2021","unstructured":"McCarthy C, Gupta N, Johnson SR et al (2021) Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med 9(11):1313\u20131327. https:\/\/doi.org\/10.1016\/S2213-2600(21)00228-9","journal-title":"Lancet Respir Med"},{"issue":"2","key":"944_CR3","doi-asserted-by":"publisher","first-page":"200007","DOI":"10.1183\/20734735.0007-2020","volume":"16","author":"AM O\u2019Mahony","year":"2020","unstructured":"O\u2019Mahony AM, Lynn E, Murphy DJ et al (2020) Lymphangioleiomyomatosis: a clinical review. Breathe (Sheff) 16(2):200007. https:\/\/doi.org\/10.1183\/20734735.0007-2020","journal-title":"Breathe (Sheff)"},{"issue":"4","key":"944_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","volume":"164","author":"J Moss","year":"2001","unstructured":"Moss J, Avila NA, Barnes PM et al (2001) Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 164(4):669\u2013671. https:\/\/doi.org\/10.1164\/ajrccm.164.4.2101154","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"944_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1378\/chest.14-3095","volume":"148","author":"AS Kristof","year":"2015","unstructured":"Kristof AS, Zhi Li P, Major P et al (2015) Lymphangioleiomyomatosis and tuberous sclerosis complex in Quebec: prevalence and health-care utilization. Chest 148(2):444\u2013449. https:\/\/doi.org\/10.1378\/chest.14-3095","journal-title":"Chest"},{"issue":"17","key":"944_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J et al (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364(17):1595\u20131606. https:\/\/doi.org\/10.1056\/NEJMoa1100391","journal-title":"N Engl J Med"},{"key":"944_CR7","doi-asserted-by":"publisher","first-page":"1328471","DOI":"10.3389\/fmed.2024.1328471","volume":"11","author":"MH Kirkeby","year":"2024","unstructured":"Kirkeby MH, Bendstrup E, Rose HK (2024) Case report: if it is not asthma-think of lymphangioleiomyomatosis in younger female patients. Front Med (Lausanne) 11:1328471. https:\/\/doi.org\/10.3389\/fmed.2024.1328471","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"944_CR8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2214\/AJR.10.4185","volume":"196","author":"NA Avila","year":"2011","unstructured":"Avila NA, Dwyer AJ, Moss J (2011) Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls. AJR Am J Roentgenol 196(4):982\u2013986. https:\/\/doi.org\/10.2214\/AJR.10.4185","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"944_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/lrb.2009.0024","volume":"8","author":"AM Taveira-DaSilva","year":"2010","unstructured":"Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J (2010) The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. Lymphat Res Biol 8(1):9\u201319. https:\/\/doi.org\/10.1089\/lrb.2009.0024","journal-title":"Lymphat Res Biol"},{"issue":"2","key":"944_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","volume":"155","author":"N Gupta","year":"2019","unstructured":"Gupta N, Lee HS, Ryu JH et al (2019) The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15 year prospective longitudinal analysis. Chest 155(2):288\u2013296. https:\/\/doi.org\/10.1016\/j.chest.2018.06.016","journal-title":"Chest"},{"issue":"4","key":"944_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","volume":"209","author":"E Lynn","year":"2024","unstructured":"Lynn E, Forde SH, Franciosi AN et al (2024) Updated prevalence of lymphangioleiomyomatosis in Europe. Am J Respir Crit Care Med 209(4):456\u2013459. https:\/\/doi.org\/10.1164\/rccm.202310-1736LE","journal-title":"Am J Respir Crit Care Med"},{"key":"944_CR12","doi-asserted-by":"publisher","first-page":"1494713","DOI":"10.3389\/fmed.2024.1494713","volume":"11","author":"V Cottin","year":"2024","unstructured":"Cottin V, Cases A, Bourdin V et al (2024) Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data. Front Med (Lausanne) 11:1494713. https:\/\/doi.org\/10.3389\/fmed.2024.1494713","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"944_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.resinv.2024.03.010","volume":"62","author":"Y Kimura","year":"2024","unstructured":"Kimura Y, Jo T, Hashimoto Y et al (2024) Epidemiology of patients with lymphangioleiomyomatosis: a descriptive study using the national database of health insurance claims and specific health checkups of Japan. Respir Investig 62(3):494\u2013502. https:\/\/doi.org\/10.1016\/j.resinv.2024.03.010","journal-title":"Respir Investig"},{"issue":"11","key":"944_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","volume":"104","author":"EC Harknett","year":"2011","unstructured":"Harknett EC, Chang WY, Byrnes S et al (2011) Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM 104(11):971\u2013979. https:\/\/doi.org\/10.1093\/qjmed\/hcr116","journal-title":"QJM"},{"issue":"5","key":"944_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","volume":"78","author":"T Urban","year":"1999","unstructured":"Urban T, Lazor R, Lacronique J et al (1999) Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d\u2019Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP). Med (Baltim) 78(5):321\u2013337. https:\/\/doi.org\/10.1097\/00005792-199909000-00004","journal-title":"Med (Baltim)"},{"issue":"9","key":"944_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/resp.14724","volume":"29","author":"M Torasawa","year":"2024","unstructured":"Torasawa M, Shukuya T, Uemura K et al (2024) Lymphangioleiomyomatosis as a potent lung cancer risk factor: insights from a Japanese large cohort study. Respirology 29(9):815\u2013824. https:\/\/doi.org\/10.1111\/resp.14724","journal-title":"Respirology"},{"issue":"8","key":"944_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3346\/jkms.2010.25.8.1182","volume":"25","author":"HY Park","year":"2010","unstructured":"Park HY, Nam HS, Chung MP et al (2010) A nationwide survey of lymphangioleiomyomatosis in Korea: recent increase in newly diagnosed patients. J Korean Med Sci 25(8):1182\u20131186. https:\/\/doi.org\/10.3346\/jkms.2010.25.8.1182","journal-title":"J Korean Med Sci"},{"issue":"1","key":"944_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12931-022-02079-6","volume":"23","author":"HY Yoon","year":"2022","unstructured":"Yoon HY, Kim HJ, Song JW (2022) Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis. Respir Res 23(1):158. https:\/\/doi.org\/10.1186\/s12931-022-02079-6","journal-title":"Respir Res"},{"issue":"1","key":"944_CR19","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-022-12314-1","volume":"12","author":"S Chang","year":"2022","unstructured":"Chang S, Choi JS, Leem AY et al (2022) Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea. Sci Rep 12(1):8260. https:\/\/doi.org\/10.1038\/s41598-022-12314-1","journal-title":"Sci Rep"},{"key":"944_CR20","doi-asserted-by":"publisher","unstructured":"Oh JH, Lee JH, Park SW et al (2026) A multicenter registry for rare interstitial lung diseases in Korea: baseline characteristics and clinical outcomes. Tuberc Respir Dis 0 https:\/\/doi.org\/10.4046\/trd.2026.0004.\u00a0","DOI":"10.4046\/trd.2026.0004"},{"issue":"10","key":"944_CR21","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","volume":"196","author":"N Gupta","year":"2017","unstructured":"Gupta N, Finlay GA, Kotloff RM et al (2017) Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American thoracic society\/Japanese respiratory society clinical practice guideline. Am J Respir Crit Care Med 196(10):1337\u20131348. https:\/\/doi.org\/10.1164\/rccm.201709-1965ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"944_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319\u2013338. https:\/\/doi.org\/10.1183\/09031936.05.00034805","journal-title":"Eur Respir J"},{"issue":"4","key":"944_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","volume":"26","author":"N Macintyre","year":"2005","unstructured":"Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26(4):720\u2013735. https:\/\/doi.org\/10.1183\/09031936.05.00034905","journal-title":"Eur Respir J"},{"issue":"3","key":"944_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4046\/trd.2005.58.3.230","volume":"58","author":"JK Choi","year":"2005","unstructured":"Choi JK, Paek D, Lee JO (2005) Normal predictive values of spirometry in Korean population. trd 58(3):230\u2013242. https:\/\/doi.org\/10.4046\/trd.2005.58.3.230","journal-title":"trd"},{"issue":"1","key":"944_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111\u2013117. https:\/\/doi.org\/10.1164\/ajrccm.166.1.at1102","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"944_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","volume":"194","author":"FX McCormack","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR et al (2016) Official American thoracic society\/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med 194(6):748\u2013761. https:\/\/doi.org\/10.1164\/rccm.201607-1384ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"944_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","volume":"173","author":"JH Ryu","year":"2006","unstructured":"Ryu JH, Moss J, Beck GJ et al (2006) The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 173(1):105\u2013111. https:\/\/doi.org\/10.1164\/rccm.200409-1298OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"944_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","volume":"12","author":"M Hayashida","year":"2007","unstructured":"Hayashida M, Seyama K, Inoue Y et al (2007) The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology 12(4):523\u2013530. https:\/\/doi.org\/10.1111\/j.1440-1843.2007.01101.x","journal-title":"Respirology"},{"issue":"1","key":"944_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2023.02.026","volume":"164","author":"W Xu","year":"2023","unstructured":"Xu W, Yang C, Cheng C et al (2023) Determinants of progression and mortality in lymphangioleiomyomatosis. Chest 164(1):137\u2013148. https:\/\/doi.org\/10.1016\/j.chest.2023.02.026","journal-title":"Chest"},{"issue":"6","key":"944_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.rmed.2003.11.013","volume":"98","author":"R Lazor","year":"2004","unstructured":"Lazor R, Valeyre D, Lacronique J et al (2004) Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis. Respir Med 98(6):536\u2013541. https:\/\/doi.org\/10.1016\/j.rmed.2003.11.013","journal-title":"Respir Med"},{"issue":"3","key":"944_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.resinv.2015.11.003","volume":"54","author":"M Hayashida","year":"2016","unstructured":"Hayashida M, Yasuo M, Hanaoka M et al (2016) Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: an analysis of the Japanese national research project on intractable diseases database. Respir Investig 54(3):193\u2013200. https:\/\/doi.org\/10.1016\/j.resinv.2015.11.003","journal-title":"Respir Investig"},{"key":"944_CR32","doi-asserted-by":"publisher","unstructured":"Taveira-DaSilva AM, Julien-Williams P, Jones AM et al (2018) Rates of change in FEV(1) and D(LCO) as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients. Eur Respir J 51(4). https:\/\/doi.org\/10.1183\/13993003.02258-2017","DOI":"10.1183\/13993003.02258-2017"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00944-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:05:38Z","timestamp":1791245138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00944-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00944-5","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of each participating center, with approval obtained from the lead institution (Asan Medical Center; IRB No. 2024-0134). For retrospectively enrolled patients, the requirement for informed consent was waived due to the use of de-identified data. Written informed consent was obtained from the prospectively enrolled patients prior to their participation in the registry.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A nationwide LAM registry of Korean patients showed that they had preserved lung function at the time of diagnosis and that the mTOR inhibitor was commonly used. Although lung function generally remained stable in patients, cough and a higher baseline function were associated with a faster decline in FEV\n                      1\n                      , highlighting the heterogeneous nature of the disease\u2019s progression.","order":4,"name":"Ethics","label":"Take Home Message","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}